CIK 0001708599
- Non-accelerated filer
- Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- Operating
- EIN
- 821436829
- Phone
- +1 256-327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-26 | LEDGER STEVEN A Chief Executive Officer | Grant or award | +10,100 | $1.93 | $19K | 10,100 |
| 2026-05-21 | LEDGER STEVEN A Chief Executive Officer | Grant or award · Stock Option (right to buy) | +380,825 | 380,825 | ||
| 2026-02-03 | LEDGER STEVEN A Chief Executive Officer | Grant or award · Stock Option (right to buy) | +230,100 | 230,100 | ||
| 2025-03-28 | LEDGER STEVEN A Chief Executive Officer | Other acquisition | +95,730 | 95,730 | ||
| 2024-09-09 | LEDGER STEVEN A Chief Executive Officer | Grant or award · Stock Option (right to buy) | +376,388 | 490,350 |
Page 1 of 1 · 5 trades